Asheesh Shipstone

Clinical trials

• Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

  Site PI · Recruiting · Phase 2

  National Cancer Institute (NCI)

  2024–2027
• Vitamin D for Prostate Endocrine Therapy

  Site PI · Recruiting · Phase 3

  University of Rochester

  2023–2029
• Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy

  Site PI · Recruiting · Phase 3

  SWOG Cancer Research Network

  2023–2031
• Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  Site PI · Recruiting · Phase 2

  National Cancer Institute (NCI)

  2023–2030